0.31%QQQQ 43.45 
0.48%XLF 21.74 3.62%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
IRVINE, Calif. - Allergan Inc., which makes Botox and breast implants, said Friday it will drop a patent-infringement lawsuit against Jan Marini Skin Research after that company agreed to stop making certain types of eyelash conditioning products.
| AGN | 54.48 |  -1.14 |
Jan Marini is one of several defendants in a patent-infringement case in the U.S District Court for the Central District of California. The dismissal is based on San Jose, Calif.-based Jan Marini acknowledging the validity of Allergan's relevant patents covering the use of certain drugs that promote eyelash enhancement.
The company also said it would stop selling products containing the ingredients in question.
Shares of Allergan fell 14 cents to close at $52.16.
The above adage is well known by precious-metals investors; in fact I used this quote in one of our monthly reports. I recall how many inquiries ...
The review was scathing. "She cannot sing very well," it said. "She is flat a go...
IN THE HEADLINES McCain caps GOP convention vowing 'change is coming' to Washing...
|
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
